. Corrigendum to "van Bommel EJM, Muskiet MHA, van Baar MJB, et al. The renal
hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by
post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in
metformin-treated patients Kidney Int 2020;97:1061.
PMID: 32331584